PTCT PTC Therapeutics Forecast, Technical & Fundamental Analysis
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders... Show more
PTCT is expected to report earnings to fall 1,034.67% to 28 cents per share on July 30
Q2'26
Est.
$0.28
Q1'26
Beat
by $0.43
Q4'25
Missed
by $1.41
Q3'25
Beat
by $1.32
Q2'25
Beat
by $0.23
The last earnings report on May 07 showed earnings per share of -2 cents, beating the estimate of -46 cents. With 6.00M shares outstanding, the current market capitalization sits at 6.08B.
A.I.dvisor indicates that over the last year, PTCT has been loosely correlated with PCVX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PTCT jumps, then PCVX could also see price increases.
PTCT in upward trend: 10-day moving average crossed above 50-day moving average on May 12, 2026
The 10-day moving average for PTCT crossed bullishly above the 50-day moving average on May 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 05, 2026. You may want to consider a long position or call options on PTCT as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PTCT just turned positive on June 09, 2026. Looking at past instances where PTCT's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
PTCT moved above its 50-day moving average on June 04, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PTCT advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The 10-day RSI Indicator for PTCT moved out of overbought territory on May 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PTCT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.645). P/E Ratio (7.508) is within average values for comparable stocks, (35.882). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.679). PTCT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.039). P/S Ratio (7.740) is also within normal values, averaging (357.394).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
